Tesaro: What’s Tearing At The Stock?

The drug maker Tesaro isn't getting much of a boost from ASCO. The stock is falling today despite some pretty bullish research notes about the launch of its new ovarian cancer treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.